CAVHANZA vs QINLOCK

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated July 29, 2026·How we rate

Possible drug interaction. CAVHANZA and QINLOCK are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	CAVHANZA	QINLOCK
Rating	New	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	NILOTINIB	RIPRETINIB
Manufacturer	Flex Pharma	Deciphera Pharms
Dosage forms	Tablet, orally disintegrating	Tablet
Drug class	Kinase Inhibitor	—
Boxed warning	None	None
Treats	Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia, Gastrointestinal Stromal Tumors	Gastrointestinal Stromal Tumors

cavhanza qinlock

Rating

New

Pharmacy pays

—

Type

Active ingredient

NILOTINIB

RIPRETINIB

Manufacturer

Flex Pharma

Deciphera Pharms

Dosage forms

Tablet, orally disintegrating

Tablet

Drug class

Kinase Inhibitor

—

Boxed warning

None

Treats

Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia, Gastrointestinal Stromal Tumors

Gastrointestinal Stromal Tumors

Frequently asked questions

What is the difference between Cavhanza and Qinlock?

Cavhanza contains Nilotinib, while Qinlock contains Ripretinib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.